Pharmacoprophylaxis of tension-type headache

Current Pain and Headache Reports

Volumn 9, Issue 6, 2005, Pages 442-447

  Lenaerts, Marc E ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; FLUVOXAMINE; LIDOCAINE; MIANSERIN; MIRTAZAPINE; MUSCLE RELAXANT AGENT; N(G) METHYLARGININE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; STEROID; TIZANIDINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

ADJUVANT THERAPY; ANALGESIC ACTIVITY; BEHAVIOR THERAPY; BULIMIA; CLINICAL TRIAL; CLUSTER HEADACHE; COGNITIVE THERAPY; CONFUSION; CONSTIPATION; DIAPHORESIS; DIPLOPIA; DISEASE EXACERBATION; DOSE CALCULATION; DRUG CHOICE; DRUG EFFICACY; DRUG FATALITY; DRUG MECHANISM; DRUG TOLERABILITY; EPISODIC TENSION HEADACHE; FEEDBACK SYSTEM; HEALTH CARE COST; HEART ARRHYTHMIA; HUMAN; INJECTION PAIN; MIGRAINE; MYDRIASIS; NAUSEA; ORTHOSTATIC HYPOTENSION; PRIMARY PREVENTION; PTOSIS; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SKIN BRUISING; SYNCOPE; TACHYCARDIA; TENSION HEADACHE; TREMOR; URINE RETENTION; VERTIGO; XEROSTOMIA;

EID: 28944448944     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-005-0025-4     Document Type: Review

References (65)

1. Lenaerts ME: Alternative therapies for tension-type headache. Curr Pain Headache Rep, 2004, 8:484-488.
2. Penzien DB, Rains JC, Lipchik GL, Creer TL: Behavioral interventions for tension-type headache: overview of current therapies and recommendation for a self-management model for chronic headache. Curr Pain Headache Rep 2004, 8:489-499.
3. Rasmussen BK, Jensen R, Schroll M, Olesen J: Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol 1991, 44:1147-1157.
4. Schwartz BS, Stewart WF, Simon MS, Lipton RB: A population-based study of the epidemiology of tension-type headache. JAMA 1998, 279:381-383.
5. Rasmussen BK, Lipton RB: Epidemiology of tension-type headache. In The Headaches, edn 2. Edited by Olesen J, Tfelt-Hansen P, Welch KM. Philadelphia: Lippincott William & Wilkins; 2000:545-550.
6. Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders, edn 2. Cephalalgia 2004, 24(suppl 1):1-160.
7. Silberstein SD, Lipton RB, Solomon S, Mathew NT: Classification of daily and near-daily headache: proposed revisions for the IHS criteria. Headache 1994, 34:1-7.
8. Silberstein SD, Lipton RB, Dalessio DJ: In Wolff's Headache and Other Head Pain, edn 7. New-York, Oxford: University Press; 2001:247-282.
9. Granella F, Farina S, Malferrari G, Manzoni GC: Drug abuse in chronic headache: a clinico-epidemiologic study. Cephalalgia 1987, 7:15-19.
10. Katsarava Z, Muessig M, Dzagnidze A, et al.: Medication-overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005, 25:12-15.
11. Holroyd KA, O'Donnell FJ, Stensland MM, et al.: Management of chronic tension-type headache with tricyclic antidepressant medication, stress-management therapy, and their combination: a randomized controlled trial. JAMA 2001, 285:2208-2215.
12. Romanek K, Holroyd KA, Cottrell C, et al.: Patterns of impairment, psychiatric comorbidity, and headache beliefs differ in migraine and tension-type headache. Headache 2005, 45:776-790.
13. Holroyd KA, Stensland M, Hill K: Separate and combined effects of cognitive-behavior therapy and antidepressant medication in the treatment of chronic tension-type headache: psychological outcomes. Headache 2005, 45:776-790.
14. Harpole LH, Samsa GF, Jurgelski AE, et al.: Headache management program improves outcome for chronic headache. Headache 2003, 43:715-724.
15. Brendza DE, Ashton K, Windover A, Stillman M: Personality Assessment inventory (PAI) predictors of therapeutic success or failure in chronic headache patients. Headache 2005, 45:776-790.
16. Göbel H, Hamouz V, Hansen C, et al.: Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity, but does not alter pericranial muscle activity readings. Pain 1994, 59:241-249.
17. Lance JW, Curran DA: Treatment of tension-type headache. Lancet 1964, 1:1236-1239.
18. Diamond S, Baltes BJ: Chronic tension headache treated with amitriptyline: a double-blind study. Headache 1971, 11:110-116.
19. Bendtsen L, Jensen R, Olesen J: A non-selective (amitriptyline), but not a selective (citalopram) serotonin reuptake inhibitor is effective in the treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 1996, 61:285-290.
20. Boz C, Altunayoglu V, Velioglu S, Ozmenoglu M: Sertraline versus amitriptyline in the prophylactic therapy of non-depressed chronic tension-type headache patients. Headache 2002, 4:72-78.
21. Benchsen L, Jensen R: Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Headache 2002, 20:603-610.
22. Ashina S, Bendtsen L, Jensen R: Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition. Pain 2004, 108:108-114.
23. Grazzi L, Andrasik F, Usai F, et al.: Pharmacological versus behavioral treatment for children and adolescents with tension-type headache: preliminary data. Neurol Sci 2004, 25:S270-S271.
24. Langemark M, Loldrup D, Bech P, Olesen J: Clomipramine and mianserin in the treatment of chronic tension-type headache: a double-blind, controlled study. Headache 1990, 30:118-121.
25. Holroyd KA, Labus JS, O'Donnell FJ, Cordingly GE: Treating chronic tension-type headache not responding to amitriptyline hydrochloride with paroxetine hydrochloride: a pilot evaluation. Headache 2003, 43:999-1004.
26. Singh NN, Misra S: Sertraline in chronic tension-type headache. J Assoc Phys India 2002, 50:873-878.
27. Adelman LC, Adelman JU, Von Seggern R, Mannix LK: Venlafaxine extended-release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 2000, 40:572-580.
28. Manna V, Bolino F, Di Cicco L: Chronic tension-type headache, mood depression, and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache 1994, 34:44-49.
29. Bendtsen L, Jensen R: Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 2004, 62:1706-1711.
30. Paiva T, Nunes JS, Moreira A, et al.: Effects of frontalis EMG biofeedback and diazepam in the treatment of tension headache. Headache 1982, 22:216-220.
31. Shukla R, Nag D, Ahuja RC: Alprazolam in chronic tension-type headache. J Assoc Phys India 1996, 44:641-644.
32. Mitsikostas DD, Gatzonis S, Thomas A, Ilias A: Buspirone versus amitriptyline in the treatment of chronic tension-type headache. Acta Neurol Scand 1997, 96:247-251.
33. Carruthers A, Langtry JA, Carruthers J, Robinson G: Improvement of tension-type headache when treating wrinkles with botulinum toxin A injections. Headache 1999, 39:662-665.
34. Rosales R, Arimura K, Takenaga S, Osame M: Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve 1996, 19:488-495.
35. Aoki KR: Pharmacology and immunology of botulinum toxin serotypes. J Neurol 2001, 248:3-10.
36. Aoki KR: Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache 2003, 43:9-15.
37. Durham PL, Cady R, Cady R: Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache 2004, 44:35-43.
38. Welch M, Purkiss JR, Foster KA: Sensitivity of embryonic rat dorsal root ganglia neurons to clostridium botulinum neurotoxins. Toxicon 2000, 38:245-258.
39. Zwart JA, Bovim G, Sand T, Sjaastad O: Tension-type headache: botulinum toxin paralysis of temporal muscles. Headache 1994, 34:458-462.
40. Schulte-Mattler WJ, Wieser T, Zierz S: Treatment of tension-type headache with botulinum toxin: a pilot study. Eur J Med Res 1999, 4:183-186.
41. Smuts JA, Baker MK, Smuts HM, et al.: Botulinum toxin type A as prophylactic treatment of chronic tension-type headache. Cephalalgia 1999, 19:454.
42. Burch CM, Kokoska MS, Glaser DA, Hollenbeak CS: Treatment of frontal tension headache with botulinum toxin A. Cephalalgia 2001, 21:489.
43. Porta M: Comparative trial of botulinum toxin type A and methylprednisolone for the treatment of tension-type headache. Curr Rev Pain 2000, 4:31-35.
44. Tepper SJ, Bigal ME, Sheftell FD, Rapoport AM: Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases. Headache 2004, 44:794-800.
45. Blumenfeld A: Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders. Headache 2003, 43:853-860.
46. Rollnik JD, Tannenberger O, Schubert M, et al.: Treatment of tension-type headache with botulinum toxin type A: a placebo-controlled study. Headache 2000, 40:300-305.
47. Schmitt WJ, Slowey E, Fravi N, et al.: Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache 2001, 41:658-664.
48. Relja M, Telarovi S: Botulinum toxin in tension-type headache. J Neurol 2004, 251:S12-S14.
49. Schulte-Mattler WJ, Krack P, BoNTTH Study Group: Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled, multicenter study. Pain 2004, 109:110-114.
50. Ondo WG, Vuong KD, Derman HS: Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study. Cephalalgia 2004, 24:60-65.
51. Padberg M, de Bruijn SF, de Haan RJ, Tavy DLJ: Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia 2004, 24:675-680.
52. Silberstein SD, Göbel H, Jensen R, et al.: The safety and efficacy of a single treatment of botulinum toxin type A in the prophylactic treatment of chronic tension-type headache (CTTH): a multicenter, double-blind, randomized, placebo-controlled, parallel-group study. Headache 2005, 45:823-840.
53. Mathew NT, Frishberg BM, Gawel M, et al.: Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache 2005, 45:293-307.
54. Eross EJ, Gladstone JP, Lewis S, et al.: Duration of migraine is a predictor for response to botulinum toxin type A. Headache 2005, 45:308-314.
55. Fogelholm R, Murros K: Tizanidine in chronic tension-type headache: a placebo-controlled, double-blind, cross-over study. Headache 1992, 32:509-513.
56. Murros K, Kataja M, Hedman C, et al.: Modified-release formulation in chronic tension-type headache. Headache 2000, 40:633-637.
57. Saper J, Lake AE III, Cantrell DT: Chronic daily headache prophylaxis with tizanidine: a double-blind, multicenter outcome study. Headache 2002, 42:470-482.
58. Lenaerts M, Bastings E, Sianard J, Schoenen J: Sodium valproate in severe migraine and tension-type headache patients: an open study of long-term efficacy and correlation with blood levels. Acta Neurol Belg 1996, 96:126-129.
59. Jensen R: Peripheral and central mechanisms in tension-type headache: an update. Cephalalgia 2003, 23:49-52.
60. Ashina M: Neurobiology of chronic tension-type headache. Cephalalgia 2004, 24:161-172.
61. Ashina S, Babenko L, Jensen R, et al.: Increased muscular and cutaneous pain sensitivity in cephalic region in patients with chronic tension-type headache. Eur J Neurol 2005, 12:543-549.
62. Wu J, Lin Q, McAdoo DJ, Willis WD: Nitric oxide contributes to central sensitization following intradermal injection of capsaicin. Neuroreport 1998, 9:589-592.
63. Ashina M, Lassen LH, Bendtsen L, et al.: Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomized, controlled trial. Lancet 1999, 353:287-289.
64. Ashina S, Ashina M: Current and potential future drug therapies for tension-type headache. Curr Headache Pain Rep 2003, 7:466-474.
65. Williams DR, Stark RJ: Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia 2003, 23:963-971.